Day

March 13, 2019
Genetech Provides Contaminated Donor-Derived Therapy

The Danger of Using Donor-derived Materials Without Good Quality Control: the Liveyon Debacle – Part One

Recently, the CDC announced to the public the existence of an outbreak of infected patients who had received a donor-derived regenerative therapy in several states: “Notes from the Field: Bloodstream and Joint Infections in Patients After Receiving Bacterially Contaminated Umbilical Cord Blood-derived Stem Cell Products for Non-hematopoietic Conditions — United States, 2018.” It isn’t a...
Read More